Company Overview and News


Add BDX
to your dashboard

Headline News

10 Super Safe Growth Stocks to Buy for Long-Lasting Dividends

20h investorplace
The stock market’s relentless march upward has pushed the prices of many companies higher. As investors bid up good and bad businesses alike, it can be hard to discern which companies are the best for long-term investors. (434-1)

5 Dividend Growth Stocks to Buy for Bigger Returns

2018-01-03 investorplace
When it comes to dividends, a large headline yield isn’t always the best choice. The reality is, stocks that grow those dividends consistently over time are actually better bets for portfolios. The combination of steadily higher dividends and capital appreciation from investors wanting those increases makes dividend growth stocks a potent choice for most portfolios. (128-0)

Blog Exposure - Becton Dickinson Completes Acquisition of C.R. Bard

2018-01-03 accesswire
LONDON, UK / ACCESSWIRE / January 03, 2018 / Active-Investors.com has just released a free research report on Becton Dickinson & Co. (NYSE: BDX) ("BD"). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=BDX as the Company’s latest news hit the wire. On December 29, 2017, the Company announced that it has completed the acquisition of C. (33-0)

Buy Carnival Corp. On Weakness - Cramer's Lightning Round (1/2/18)

2018-01-03 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, January 2. (75-0)

Wired News - The U.S. FTC Conditionally Approves Becton, Dickinson and Co.'s Takeover of C.R. Bard

2017-12-27 accesswire
LONDON, UK / ACCESSWIRE / December 27, 2017 / Active-Investors.com has just released a free research report on Becton, Dickinson and Co. (NYSE: BDX) ("BD"). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=BDX as the Company's latest news hit the wire. On December 22, 2017, the Company, a leading global medical technology organization, declared that the U. (71-0)

Stellar Metrics for Earnings Growth Keep Becton Dickinson & Co (BDX) a Strong Buy

2017-12-12 investorplace
Becton Dickinson & Co (NYSE:BDX) is a constituent of the 161 company Health Care Equipment & Supplies GICS industry group, which is part of the 782 company GICS Health Care sector. The market value of BDX is $50.1 billion which falls in the top 10% of its industry group. Portfolio Grader's current ranking for BDX puts it 17 among the 161 companies in this industry group, giving it a well above-average position; in the top decile of the sector with a ranking of 46 among the 782 companies in the sector, and number 268 in the nearly 5,000 company Portfolio Grader universe. (33-0)

Superb Quant Score Makes Becton Dickinson & Co (BDX) a Strong Buy

2017-12-05 investorplace
Becton Dickinson & Co (NYSE:BDX) is ranked as a Strong Buy using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for the last month. (33-0)

BD Stock Reaches 52-Week High on November 27

2017-11-29 marketrealist
BD (BDX) reached a 52-week high of $227.80 on November 27, 2017. The company saw a 52-week low of $161.30 on December 7, 2017. BD stock’s 50-day moving average stands at $213.80, and its 200-day moving average is $200.33. The company is currently trading higher than these moving averages. (97-0)

Becton Dickinson & Co (BDX) a Strong Buy on Best-in-Class Quant Score

2017-11-28 investorplace
Becton Dickinson & Co (NYSE:BDX) is one of the 781 companies in the GICS Health Care sector, and a member of the 161 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of BDX is $51.6 billion which places it in the top decile in its industry group. Currently, the stock's Portfolio Grader ranking places it 18 among the 161 companies in this industry group, placing it among the leaders; in the top decile of the sector with a ranking of 55 among the 781 companies in the sector, and number 301 in the nearly 5,000 company Portfolio Grader universe. (33-0)

Tracking Al Gore's Generation Investment Management Portfolio - Q3 2017 Update

2017-11-25 seekingalpha
The top three positions are Cerner, Acuity Brands, and Microsoft, and they add up to ~23% of the entire portfolio. (392-1)

Medtronic’s 2Q18 Earnings Surpassed Analysts’ Estimates

2017-11-24 marketrealist
Medtronic’s 2Q18 results surpassed analysts’ estimates despite a number of factors that hurt the company’s performance. Medtronic reported its 2Q18 results on November 21, 2017. The company’s adjusted diluted EPS (earnings per share) in the quarter were $1.07, representing a YoY (year-over-year) increase of around 2%. The earnings results exceeded Wall Street analysts’ estimates of around $0.98 per share. (121-0)

Global In Vitro Diagnostic Market Booms: Stocks in Focus

2017-11-22 zacks
The FDA approvals of Roche Holdings’ (RHHBY - Free Report) Hemlibra or Cobas Cdiff Nucleic acid test and Thermo Fisher Scientific’s (TMO - Free Report) slew of advancements in next-generation sequencing (the latest one being the FDA approved Oncomine Dx Target Test) clearly point toward the rapid emergence of in vitro diagnostics (IVD) in the MedTech space. The recent EvaluateMedTech World Preview indicates that while worldwide MedTech sales are expected to witness CAGR of 5. (99-0)

Becton Dickinson & Co (BDX) a Strong Buy on Stellar Earnings Growth

2017-11-21 investorplace
Becton Dickinson & Co (NYSE:BDX) is ranked as a Strong Buy using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. BDX has recently seen its Portfolio Grader rating upgraded from a Buy to a Strong Buy. (33-1)

7 ETFs and Mutual Funds to Weather Bear Territory | InvestorPlace

2017-11-20 investorplace
After eight long years of gains, the bull may be getting a tad bit tired. Stock valuations are near historic highs, there has been some weakness with economic data and the markets have recently begun to take a breather. It seems that the bull might be running out of steam. (66-2)

Featured Company News - Merit Medical Signs Agreement with Becton, Dickinson & Co. to Acquire Divestment Assets

2017-11-20 accesswire
LONDON, UK / ACCESSWIRE / November 20, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Merit Medical Systems, Inc. (NASDAQ: MMSI) ("Merit"), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=MMSI. The Company announced on November 16, 2017, that it has entered into a purchase agreement with Becton, Dickinson and Co. (86-1)

CUSIP: 075887109